Insomnia in Glatopa - how severe and when it was recovered? (a real world drug study)
Summary:
There is no report of severity or recovery of Insomnia by people who take Glatopa yet.
What is Glatopa?
Glatopa has active ingredients of glatiramer acetate. eHealthMe is studying from 6,518 Glatopa users. Check the latest studies of Glatopa.
What is Insomnia?
Insomnia (sleeplessness) is found to be associated with 3,115 drugs and 5,173 conditions by eHealthMe. Check the latest studies of Insomnia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
No report is found.
Do you take Glatopa and have Insomnia?
Check whether Insomnia is associated with a drug or a conditionHow to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
How the study uses the data?
The study is based on glatiramer acetate (the active ingredients of Glatopa). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Doxorubicin Hydrochloride and Progressive Multifocal Leukoencephalopathy for Men aged 50-59 - now
- Drug interactions of Promethazine and Aldactone - 4 seconds ago
- Chronic Kidney Disease and drugs of ingredients of methylphenidate - 5 seconds ago
- Diarrhea Aggravated and drugs of ingredients of capmatinib hydrochloride - 8 seconds ago
- Could Emla cause Nausea And Vomiting? - 8 seconds ago
- Pancreatitis and drugs of ingredients of bumetanide - 8 seconds ago
- Drug interactions of Acetic Acid and Metronidazole - 8 seconds ago
- Eye Disorder and drugs of ingredients of venetoclax - 8 seconds ago
- Could Mirena cause Interstitial Lung Disease? - 8 seconds ago
- Remodulin and Joint Swelling for Women aged 30-39 - 9 seconds ago